Pharmacological inhibition of PLK1/PRC1 triggers mitotic catastrophe and sensitizes lung cancers to chemotherapy

Pingping Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Guohai Zhang(Guangxi Normal University), Lingling Wang(SLAC National Accelerator Laboratory), Hong Liang(Central South University), Yongkun Li(Shandong University), Min Lu(South China Agricultural University), Yan Peng(Guangxi Normal University), Cheng‐Fei Chen(Guangxi Normal University), Shulan Zeng(Guangxi Normal University)
Cell Death and Disease
May 12, 2025
10.1038/s41419-025-07708-8
Cited by 6

Related Papers

TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription
|Nature Communications|2019|254
Proteome Analysis of Hepatocellular Carcinoma by Two-dimensional Difference Gel Electrophoresis
|Molecular & Cellular Proteomics|2007|247
Macroscopic somatic clonal expansion in morphologically normal human urothelium
|Science|2020|221
Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway
|Journal of Experimental & Clinical Cancer Research|2021|182
Inhibition of Ca2+-activated Cl− channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinoma
|Cancer Letters|2012|168